The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease

E-ISSN： 1875-5607|15|14|1187-1194

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.15, Iss.14, 2015-12, pp. : 1187-1194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Redox Homeostasis and Epigenetics in Non-alcoholic Fatty Liver Disease (NAFLD)

Current Pharmaceutical Design, Vol. 19, Iss. 15, 2013-03 ,pp. : 2737-2746

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Lipid Species Linked to the Progression of Non-alcoholic Fatty Liver Disease

Current Drug Targets, Vol. 16, Iss. 12, 2015-10 ,pp. : 1293-1300

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic fatty liver disease

By Federico Alessandro Niosi Marco Vecchio Blanco Camillo Del Loguercio Carmela

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 145-158

Informa Healthcare

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease: a massive problem

By Day Christopher P

Clinical Medicine, Vol. 11, Iss. 2, 2011-04 ,pp. : 176-178

Royal College Of Physicians

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-01 ,pp. : 2193-2198

Bentham Science Publishers

Access to resources Recommend Favorite